Do changes in interfraction organ at risk volume and cylinder insertion geometry impact delivered dose in high-dose-rate vaginal cuff brachytherapy?

被引:9
|
作者
Patel, Shyamal [1 ]
Mehta, Keyur J. [1 ]
Kuo, Hsiang-Chi G. [1 ]
Ohri, Nitin [1 ]
Patel, Rajal [1 ]
Yaparpalvi, Ravi [1 ]
Garg, Madhur K. [1 ]
Guha, Chandan [1 ]
Kalnicki, Shalom [1 ]
机构
[1] Montefiore Med Ctr, Dept Radiat Oncol, 111 East 210th St,1st Floor Yellow Zone, Bronx, NY 10467 USA
关键词
Vaginal cuff brachytherapy; HDR vaginal brachytherapy; Cylinder insertion geometry; Organ at risk volume; Interfraction dose variance; GYNECOLOGIC-ONCOLOGY-GROUP; ENDOMETRIAL CANCER; AMERICAN BRACHYTHERAPY; VAULT BRACHYTHERAPY; RADIATION-THERAPY; SOCIETY; IRRADIATION; CARCINOMA; PATTERNS; SURGERY;
D O I
10.1016/j.brachy.2015.11.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE: Within a multifraction high-dose-rate vaginal cuff brachytherapy course, we determined if individual variations in organ at risk (OAR) volume and cylinder insertion geometry (CIG) impacted dose and whether planned minus fractional (P - F) differences led to a discrepancy between planned dose and delivered dose. METHODS AND MATERIALS: We analyzed vaginal cuff brachytherapy applications from consecutive patients treated with three fractions of 5 Gy after each undergoing a planning CT and three repeat fractional CTs (fCTs). Rectal and bladder D-2ccs and volumes were recorded in addition to the x (in relationship to midplane) and y (in relationship to the table) angles of CIG. Paired t-tests and multiple regression analyses were performed. RESULTS: Twenty-seven patients were identified. In comparing the planning CT vs. mean fCT rectal volumes, bladder volumes, x angles, and y angles, only bladder volume was significantly different (planned volume higher, t = 2.433, p = 0.017). The cumulative mean planned OAR D-2cc vs. delivered D-2cc was only significantly different for the bladder (planned dose lower, t = -2.025, p = 0.053). Regression analysis revealed planned rectal D-2cc (p < 0.0003) and a positive (posterior) y insertion angle (p = 0.015) to significantly impact delivered rectal D2cc. Additionally, P F rectal volume (p = 0.037) was significant in determining rectal delivered dose. CONCLUSIONS: A more posterior y angle of insertion was found to increase rectal D-2cc leading us to believe that angling the vaginal cylinder anteriorly may reduce rectal dose without significantly increasing bladder dose. Although attention should be paid to OAR volume and CIG to minimize OAR dose, the clinical significance of P - F changes remains yet to be shown. 2016 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:185 / 190
页数:6
相关论文
共 50 条
  • [31] Dosimetric comparison of multichannel with one single-channel vaginal cylinder for vaginal cancer treatments with high-dose-rate brachytherapy
    Kim, Hayeon
    Rajagopalan, Malolan S.
    Houser, Chris
    Beriwal, Sushil
    BRACHYTHERAPY, 2014, 13 (03) : 263 - 267
  • [32] The Dosemetric Impact of Multichannel Vaginal Cylinder Applicator Rotation in High Dose Rate Gynecological Brachytherapy
    Ashenafi, M.
    Matloubieh, A.
    Hare, M.
    Gray, A.
    MEDICAL PHYSICS, 2020, 47 (06) : E492 - E493
  • [33] High-dose-rate brachytherapy delivered in two fractions as monotherapy for low-risk prostate cancer
    Cendales, Ricardo
    Alwers, Elizabeth
    Cifuentes, Javier
    Bobadilla, Ivan
    Torres, Felipe
    Arbelaez, Juan
    Goiton, Armando
    Cortes, Helber
    Acevedo, Yenny
    Quintero, Paulo
    Vasquez, Jaider
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2015, 7 (01) : 10 - 16
  • [34] High-Dose-Rate Brachytherapy for primary vaginal melanoma treatment: a case report
    Pappalardi, B.
    Delle Curti, C. T.
    Piccolo, F.
    Tenconi, C.
    Giandini, T.
    Carrara, M.
    Cerrotta, A.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S596 - S597
  • [35] Urethral dosimetry and toxicity with high-dose-rate interstitial brachytherapy for vaginal cancer
    Rajagopalan, Malolan S.
    Kannan, Neeta
    Kim, Hayeon
    Houser, Christopher J.
    Beriwal, Sushil
    BRACHYTHERAPY, 2013, 12 (03) : 248 - 253
  • [36] Intracavitary hyperthermia and brachytherapy high-dose-rate in vaginal recurrences of uterine cancer
    Parisi, S
    Raguso, A
    Troiano, M
    Corsa, P
    Canistro, A
    Cossa, S
    El Jaouni, M
    TUMORI, 2001, 87 (04) : S130 - S130
  • [37] High-dose-rate brachytherapy for vaginal cancer: Learning from treatment complications
    Tyree, WC
    Cardenes, H
    Randall, M
    Papiez, L
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2002, 12 (01) : 27 - 31
  • [38] High-dose-rate intracavitary brachytherapy in the management of cervical and vaginal intraepithelial neoplasia
    Ogino, I
    Kitamura, T
    Okajima, H
    Matsubara, S
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 40 (04): : 881 - 887
  • [39] Customized high-dose-rate brachytherapy using MRI planning for vaginal rhabdomyosarcoma
    Hathout, Lara
    Cohn, Jamie
    Voros, Laszlo
    Kim, Sae Hee
    Heaton, Todd
    Wolden, Suzanne L.
    BRACHYTHERAPY, 2015, 14 (01) : 46 - 50
  • [40] A unique approach to high-dose-rate vaginal mold brachytherapy of gynecologic malignancies
    Nilsson, Sanna
    Moutrie, Zoe
    Cheuk, Robyn
    Chan, Philip
    Lancaster, Craig
    Markwell, Tim
    Dawes, Jodi
    Back, Phil
    BRACHYTHERAPY, 2015, 14 (02) : 267 - 272